12 Oct Charles River Laboratories

Posted at 18:22h in by Brittany Miller

Ramin Baghirzade, Ph.D., Global Head Commercial, Gene Therapy CDMO Services

Oct. 12 | 2:00pm | Oxford Biomedica Ballroom

Wilmington, MA

(NASDAQ: CRL)

In-person Presentation

A CRO/CDMO with 75 years experience bringing therapeutics to market. Charles River now has a concept-to-commercial portfolio in cell and gene therapy enabling partners to reduce the number of complex external relationships which need to be managed. This serves to simplify the CRO/CDMO relationship and speed time to clinic and commercial.

www.criver.com

About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 10-12, 2023
Park Hyatt Aviara
Carlsbad, CA

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions